HMGB1 mediates endogenous TLR2 activation and brain tumor regression.

HMGB1 mediates endogenous TLR2 activation and brain tumor regression.

<h4>Background</h4>Glioblastoma multiforme (GBM) is the most aggressive primary brain tumor that carries a 5-y survival rate of 5%. Attempts at eliciting a clinically relevant anti-GBM immune response in brain tumor patients have met with limited success, which is due to brain immune pri...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: James F Curtin, Naiyou Liu, Marianela Candolfi, Weidong Xiong, Hikmat Assi, Kader Yagiz, Matthew R Edwards, Kathrin S Michelsen, Kurt M Kroeger, Chunyan Liu, A K M Ghulam Muhammad, Mary C Clark, Moshe Arditi, Begonya Comin-Anduix, Antoni Ribas, Pedro R Lowenstein, Maria G Castro
Format: article
Langue:EN
Publié: Public Library of Science (PLoS) 2009
Sujets:
Medicine
R
Accès en ligne:https://doaj.org/article/0adb0547db44421eb3369a03d288ff9a
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/0adb0547db44421eb3369a03d288ff9a

Documents similaires